Access keys | Skip to content | Skip to footer |
Problems viewing this site
*
Home > Smart State Strategy > Smart State Progress Report highlights 2006/07 > Research to create tomorrow's ideas

Research to create tomorrow's ideas

Queensland's expanding research capacity is creating the ideas for new industries and technologies as well as stimulating and reinvigorating existing industries. The Queensland Government is investing heavily in developing an innovative research culture with world-class infrastructure and attracting leading researchers that are internationally recognised and deliver benefits to Queensland.

Increased funding to support research and development: Queensland Government invests $60 per person on research, more than NSW ($44) and Victoria ($40) and 50 per cent more than Commonwealth Government research spending in Queensland ($41).

Queensland - a leading State in R&D investment

Queensland higher education expenditure orientated towards commercial research: In 2004, Queensland universities allocated 59.1 per cent of their expenditure on R&D to applied research and experimental development; higher than in any other state and above the Australian average of 48.4 per cent.

Queensland's sucess with Smart Exports

Last reviewed 24 October 2006
^ to top

Blockbuster drug discovery

The discovery of the cause of cervical cancer and subsequent development of a vaccine, which has received US Food and Drug Administration approval and has just been released for sale in Australia, is expected to remain one of the most significant medical discoveries of the 21st century.

Professor Ian Frazer, based at the University of Queensland and undertaking research within the Princess Alexandra Hospital, has developed the vaccine against cervical cancer, a disease which currently kills around 270 000 women each year. Professor Ian Frazer has been awarded the inaugural 2006 Smart State Premier's Fellowship Award and has also been made 2006 Australian of the Year. His research in Queensland will look to translate the immunotherapy success of the cervical cancer vaccine to other cancers and infections.